Citation Impact
Citing Papers
The gut microbiota influences blood-brain barrier permeability in mice
2014 Standout
Caveolae-mediated Internalization of Occludin and Claudin-5 during CCL2-induced Tight Junction Remodeling in Brain Endothelial Cells
2009
Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy
2015
Molecular Determinants of the Interaction between Clostridium perfringens Enterotoxin Fragments and Claudin-3
2009
Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence
2001
The Active Conformation of β-Arrestin1
2007 StandoutNobel
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
2011 Standout
Kappa Opioid Receptor Activation of p38 MAPK Is GRK3- and Arrestin-dependent in Neurons and Astrocytes
2006
Psychopharmacology of conditioned reward: evidence for a rewarding signal at D 1 -like dopamine receptors
1999
NF-κB signaling in inflammation
2017 Standout
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
2004 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release
2006
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
From Threat to Fear: The Neural Organization of Defensive Fear Systems in Humans
2009 StandoutNobel
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
2006 StandoutNobel
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
2017 Standout
Lipopolysaccharide-Activated Microglia Induce Dysfunction of the Blood–Brain Barrier in Rat Microvascular Endothelial Cells Co-Cultured with Microglia
2009
Botulinum neurotoxin light chains inhibit both Ca2+‐induced and GTP analogue‐induced catecholamine release from permeabilised adrenal chromaffin cells
1996
Involvement of ROS in BBB dysfunction
2009
The Lifelong Effects of Early Childhood Adversity and Toxic Stress
2011 Standout
A neuroendocrine role in cocaine reinforcement
1997
Function and Regulation of CREB Family Transcription Factors in the Nervous System
2002 Standout
Dopamine Partial Agonists
2004
Blood–Brain Barrier Pathophysiology in Traumatic Brain Injury
2011
Effects of stress throughout the lifespan on the brain, behaviour and cognition
2009 Standout
Arrestin Development: Emerging Roles for β-arrestins in Developmental Signaling Pathways
2009 StandoutNobel
The adolescent brain and age-related behavioral manifestations
2000 Standout
Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions
2010
Prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and serotonin transporter promoter genotype (SLC6A4) influence executive functions at 6 years of age
2013
SNAREpins: Minimal Machinery for Membrane Fusion
1998 StandoutNobel
Dopamine System Stabilizers, Aripiprazole, and the Next Generation of Antipsychotics, Part 2: Illustrating Their Mechanism of Action
2001
A New Structural Motif for Bifunctional Brønsted Acid/Base Organocatalysis
2010 StandoutNobel
The Neural Basis of Addiction: A Pathology of Motivation and Choice
2005 Standout
Disruption of central nervous system barriers in multiple sclerosis
2010
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Acute Selective Serotonin Reuptake Inhibitors Increase Conditioned Fear Expression: Blockade With a 5-HT2C Receptor Antagonist
2007
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
2016 Standout
Prostaglandin F2α Treatment In Vivo, but Not In Vitro, Stimulates Protein Kinase C-Activated Superoxide Production by Nonsteroidogenic Cells of the Rat Corpus Luteum1
1998
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Drug repurposing: progress, challenges and recommendations
2018 Standout
HIV‐1 gp120 as Well as Alcohol Affect Blood–Brain Barrier Permeability and Stress Fiber Formation: Involvement of Reactive Oxygen Species
2006
Connexin-43 induces chemokine release from spinal cord astrocytes to maintain late-phase neuropathic pain in mice
2014
Intestinal mucosal barrier function in health and disease
2009 Standout
Host microbiota constantly control maturation and function of microglia in the CNS
2015 Standout
Stress and the brain: from adaptation to disease
2005 Standout
Therapeutic effects of lysophosphatidylcholine in experimental sepsis
2004
Pathophysiological Basis of Vulnerability to Drug Abuse: Role of an Interaction Between Stress, Glucocorticoids, and Dopaminergic Neurons
1996
The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction
2008
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
2016 Standout
The Blood-Brain Barrier and Its Role in Immune Privilege in the Central Nervous System
2003
Differential effects of hydrocortisone and TNFα on tight junction proteins in an in vitro model of the human blood–brain barrier
2008
Radical changes in multiple sclerosis pathogenesis
2010
Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery
2008
G‐protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal
2004 StandoutNobel
Specific Role of Tight Junction Proteins Claudin-5, Occludin, and ZO-1 of the Blood–Brain Barrier in a Focal Cerebral Ischemic Insult
2011
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
2010
LTP and LTD
2004 Standout
A Catalytic Asymmetric 6 π Electrocyclization: Enantioselective Synthesis of 2‐Pyrazolines
2009 StandoutNobel
Gut microbiota, metabolites and host immunity
2016 Standout
The biopsychosocial approach to chronic pain: Scientific advances and future directions.
2007 Standout
Effects of surgical and pharmacological adrenalectomy on the initiation and maintenance of intravenous cocaine self-administration in rats
1996
"Dopamine System Stabilizers, Aripiprazole, and the Next Generation of Antipsychotics, Part 1: "Goldilocks" Actions at Dopamine Receptors
2001
Brain endothelial cells and the glio-vascular complex
2008
Effects of perinatal mental disorders on the fetus and child
2014 Standout
The Darwinian concept of stress: benefits of allostasis and costs of allostatic load and the trade-offs in health and disease
2004
Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety
1999 Standout
The Pathobiology of Vascular Dementia
2013 Standout
Pericytes regulate the blood–brain barrier
2010 StandoutNature
The blood–brain barrier in health and disease
2012
GWAS analysis implicates NF-κB-mediated induction of inflammatory T cells in multiple sclerosis
2016
Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies
2000
CD11c/EYFP transgene illuminates a discrete network of dendritic cells within the embryonic, neonatal, adult, and injured mouse brain
2008 StandoutNobel
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
P2X7 receptor activation induces CXCL2 production in microglia through NFAT and PKC/MAPK pathways
2010
Lysophospholipids and Their Receptors Serve as Conditional DAMPs and DAMP Receptors in Tissue Oxidative and Inflammatory Injury
2017
Occludin Protein Family: Oxidative Stress and Reducing Conditions
2011
A Phosphine‐Catalyzed Regioselective [3+2] Cycloaddition of Ethyl 5,5‐Diarylpenta‐2,3,4‐trienoate with Aromatic Aldehydes and α,β‐Unsaturated Carbonyl Compounds
2014
Vascular cell adhesion molecule 1 (VCAM-1) activation of endothelial cell matrix metalloproteinases: role of reactive oxygen species
2004
Microvascular protection is essential for successful neuroprotection in stroke
2012
Protecting against vascular disease in brain
2011
Role of Nrf2 in Oxidative Stress and Toxicity
2013 Standout
Pain regulation by non-neuronal cells and inflammation
2016 StandoutScience
Phosphine Organocatalysis
2018 Standout
Involvement of cAMP-Dependent Protein Kinase in the Nucleus Accumbens in Cocaine Self-Administration and Relapse of Cocaine-Seeking Behavior
1998
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Microglia Function in the Central Nervous System During Health and Neurodegeneration
2017 Standout
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
β-Arrestins and Cell Signaling
2007 StandoutNobel
Insertional Mutagenesis by a Hybrid PiggyBac and Sleeping Beauty Transposon in the Rat
2012
Drug Abuse: Hedonic Homeostatic Dysregulation
1997 StandoutScience
Selective Decrease in Paracellular Conductance of Tight Junctions: Role of the First Extracellular Domain of Claudin-5
2004
Suppression of glucocorticoid secretion and antipsychotic drugs have similar effects on the mesolimbic dopaminergic transmission
1996
Agrin, Aquaporin-4, and Astrocyte Polarity as an Important Feature of the Blood-Brain Barrier
2009
Claudins and the Modulation of Tight Junction Permeability
2013 Standout
Complete Field Guide to Asymmetric BINOL-Phosphate Derived Brønsted Acid and Metal Catalysis: History and Classification by Mode of Activation; Brønsted Acidity, Hydrogen Bonding, Ion Pairing, and Metal Phosphates
2014 Standout
Neurotoxins Affecting Neuroexocytosis
2000 Standout
Eine katalytische asymmetrische 6π‐Elektrocyclisierung: enantioselektive Synthese von 2‐Pyrazolinen
2009 StandoutNobel
Physiology of Microglia
2011 Standout
Works of Eric Ronken being referenced
Interacting Presynaptic k ‐Opioid and GABAA Receptors Modulate Dopamine Release from Rat Striatal Synaptosomes
1993
Acute effects of oxidized low density lipoprotein on metabolic responses in macrophages
1998
Serotonin transporter deficiency in rats improves inhibitory control but not behavioural flexibility
2007
Glucocorticoid and mineralocorticoid receptors differentially modulate cultured dopaminergic neurons of rat ventral mesencephalon
1994
Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier
2012
Neonatal basolateral amygdala lesions affect monoamine and cannabinoid brain systems in adult rats
2006
Patterns of c-fos expression induced by fluvoxamine are different after acute vs. chronic oral administration
1998
Sphingosine 1‐phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions
2010
Differential regulation of the CXCR2 chemokine network in rat brain trauma: Implications for neuroimmune interactions and neuronal survival
2006
Protective effects of peroxiredoxin-1 at the injured blood–brain barrier
2008
Characterization of the serotonin transporter knockout rat: A selective change in the functioning of the serotonergic system
2007
Repeated and chronic morphine administration causes differential long-lasting changes in dopaminergic neurotransmission in rat striatum without changing its δ- and κ-opioid receptor regulation
1994
Overexpression of corticotropin‐releasing hormone in transgenic mice and chronic stress‐like autonomic and physiological alterations
2002
Neuromethods, vol. 20 ‘intracellular messengers’
1993
Synthesis, Biological Properties, and Molecular Modeling Investigations of Novel 3,4-Diarylpyrazolines as Potent and Selective CB1 Cannabinoid Receptor Antagonists
2003
Reactive oxygen species enhance the migration of monocytes across the blood‐brain barrier in vitro
2001
DU 127090: a highly potent, atypical dopamine receptor ligand — high potency but low efficacy at dopamine D2 receptors in vitro
2000
DU 127090: A novel partial dopamine agonist with antipsychotic activity high potency but low efficacy at dopamine D2 receptors in vitro
2003
Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling
2007
SLV313 is a dopamine D2 receptor antagonist and serotonin 5-HT1A receptor agonist: In vitro and in vivo neuropharmacology
2002
Chronic activation of mu- and kappa-opioid receptors in cultured catecholaminergic neurons from rat brain causes neuronal supersensitivity without receptor desensitization.
1994